The Trouble with Tribbles: Do Antibodies Against TRIB2 Cause Narcolepsy?

被引：25

作者：

Lim, Andrew S. P. ^{[1
]}

Scammell, Thomas E. ^{[1
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA

来源：

SLEEP | 2010年 / 33卷 / 07期

关键词：

PARKINSONS-DISEASE;

D O I：

10.1093/sleep/33.7.857

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：857 / 858

页数：2

共 40 条

[21] TRIB2 modulates proteasome function to reduce ubiquitin stability and protect liver cancer cells against oxidative stress
Susu Guo
Yuxin Chen
Yueyue Yang
Xiao Zhang
Lifang Ma
Xiangfei Xue
Yongxia Qiao
Jiayi Wang
Cell Death & Disease, 12
[22] TRIB2 modulates proteasome function to reduce ubiquitin stability and protect liver cancer cells against oxidative stress
Guo, Susu
Chen, Yuxin
Yang, Yueyue
Zhang, Xiao
Ma, Lifang
Xue, Xiangfei
Qiao, Yongxia
Wang, Jiayi
CELL DEATH & DISEASE, 2021, 12 (01)
[23] Targeting tribbles homolog 3 (TRIB3) protein against type 2 diabetes for the identification of potential inhibitors by in silico screening
Lanka, Goverdhan
Bhargavi, Manan
Bathula, Revanth
Potlapally, Sarita Rajender
JOURNAL OF THE INDIAN CHEMICAL SOCIETY, 2022, 99 (07)
[24] Impaired Phosphorylation and Ubiquitination by p70 S6 Kinase (p70S6K) and Smad Ubiquitination Regulatory Factor 1 (Smurf1) Promote Tribbles Homolog 2 (TRIB2) Stability and Carcinogenic Property in Liver Cancer
Wang, Jiayi
Zhang, Yue
Weng, Wenhao
Qiao, Yongxia
Ma, Lifang
Xiao, Weifan
Yu, Yongchun
Pan, Qiuhui
Sun, Fenyong
JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (47) : 33667 - 33681
[25] EXPERIMENTAL INACTIVATED VIRUS-VACCINE AGAINST BOVINE EPHEMERAL FEVER .2. DO NEUTRALIZING ANTIBODIES PROTECT AGAINST INFECTION
DELLAPORTA, AJ
SNOWDON, WA
VETERINARY MICROBIOLOGY, 1979, 4 (03) : 197 - 208
[26] NATURAL ANTIBODIES AGAINST THE IMMUNOGLOBULIN F(AB')(2) FRAGMENT CAUSE ELIMINATION OF ANTIGENS RECOGNIZED BY THE F(AB')(2) FROM THE CIRCULATION
YANO, S
KAKU, S
SUZUKI, K
TERAZAKI, C
SAKAYORI, T
KAWASAKI, T
KAWAMURA, K
SUGITA, Y
HOSHINO, K
MASUHO, Y
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (11) : 3128 - 3133
[27] Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease
Zhou, Panpan
Song, Ge
Liu, Hejun
Yuan, Meng
He, Wan-ting
Beutler, Nathan
Zhu, Xueyong
Tse, Longping V.
Martinez, David R.
Schafer, Alexandra
Anzanello, Fabio
Yong, Peter
Peng, Linghang
Dueker, Katharina
Musharrafieh, Rami
Callaghan, Sean
Capozzola, Tazio
Limbo, Oliver
Parren, Mara
Garcia, Elijah
Rawlings, Stephen A.
Smith, Davey M.
Nemazee, David
Jardine, Joseph G.
Safonova, Yana
Briney, Bryan
Rogers, Thomas F.
Wilson, Ian A.
Baric, Ralph S.
Gralinski, Lisa E.
Burton, Dennis R.
Andrabi, Raiees
IMMUNITY, 2023, 56 (03) : 669 - +
[28] Antiphospholipid antibodies with LAC activity that bind beta2-glycoprotein I cause increased resistance against activated protein C
de laat, Bas
Meijer, Sander B.
Eckmann, Carel M.
van Schagen, M.
Mertens, Koen
van Mourik, Jan A.
BLOOD, 2007, 110 (11) : 1060A - 1060A
[29] Do preexisting antibodies against seasonal coronaviruses have a protective role against SARS-CoV-2 infections and impact on COVID-19 severity?
Nasrallah, Gheyath K.
EBIOMEDICINE, 2022, 76
[30] Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents
Ratcliffe, Helen
Tiley, Karen S.
Longet, Stephanie
Voysey, Merryn
Tonry, Claire
Roarty, Cathal
Watson, Chris
Amirthalingam, Gayatri
Vichos, Iason
Morey, Ella
Douglas, Naomi L.
Marinou, Spyridoula
Plested, Emma
Aley, Parvinder K.
Galiza, Eva
Faust, Saul N.
Hughes, Stephen
Murray, Clare
Roderick, Marion R.
Turner, Paul J.
Cockerill, Helen
Bernal, Jamie Lopez
Ijaz, Samreen
Poh, John
Shute, Justin
Linley, Ezra
Borrow, Ray
Hoschler, Katja
Shackley, Fiona
Brown, Kevin E.
Oddie, Sam
Carroll, Miles W.
Klenerman, Paul K.
Dunachie, Susanna J.
Ramsay, Mary
Waterfield, Thomas
Snape, Matthew D.
Lee, Tim W. R.
Turner, David P. J.
Raman, Mala
Owens, Stephen
ISCIENCE, 2023, 26 (12)

← 1 2 3 4 →